Biotechnology Companies

被引：0

|

作者：

Sean P. Polster

机构：

[1] University of Minnesota-Lillehei Heart Institute,Department of Medicine

来源：

Journal of Cardiovascular Translational Research | 2008年 / 1卷 / 2期

关键词：

D O I：

10.1007/s12265-008-9028-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 102

页数：1

相关论文

共 50 条

[31] Why biotechnology and pharmaceutical companies are working together
Devine, P
[J]. AUSTRALASIAN BIOTECHNOLOGY, 2002, 12 (04) : 52 - 53
[32] BIOTECHNOLOGY COMPANIES - ONE FALTERS, ANOTHER FORMS
NEWMARK, P
[J]. NATURE, 1986, 324 (6096) : 402 - 402
[33] CONFIDENT COMPANIES FORESEE BIOTECHNOLOGY EXPANSION IN EUROPE
DICKSON, D
[J]. NATURE, 1995, 374 (6522) : 488 - 488
[34] US biotechnology companies look to Europe and Japan
Dibner, MD
Bullock, WO
[J]. BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS, 1995, 8 (08): : 28 - 30
[35] News of biotechnology Attorneys, regulatory professionals, and companies
不详
[J]. BIOTECHNOLOGY LAW REPORT, 1997, 16 (03): : 398 - 401
[36] Strategic HR for today's biotechnology companies
Mary Yaroshevsky-Glanville
[J]. Nature Biotechnology, 2004, 22 : 1189 - 1189
[37] Due diligence in acquiring biotechnology companies.
Walsh, AC
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U389 - U389
[38] Evaluating the performance of biotechnology companies by causal recipes
Huang, Chieh-Wei
Huarng, Kun-Huang
[J]. JOURNAL OF BUSINESS RESEARCH, 2015, 68 (04) : 851 - 856
[39] Strategic HR for today's biotechnology companies
Yaroshevsky-Glanville, M
[J]. NATURE BIOTECHNOLOGY, 2004, 22 (09) : 1189 - 1189
[40] Platform technology management of biotechnology companies in Japan
Arato, Shunichi
Kano, Shingo
[J]. 1600, ThinkBiotech LLC (26): : 39 - 50

← 1 2 3 4 5 →